Humanized MN-14 monoclonal antibody targeted to carcinoembryonic antigen data

IMMU published in Cancer Research results of a trial in 17 patients with medullary thyroid cancer, showing limited tumor responses in 5 of 11 assessable patients, lasting up to 26 months. ...